abstract |
Compositions and methods are provided for alleviating cancer in a mammal by nadministering a therapeutic dose of a pharmaceutical composition that inhibits activity nof AXL, MER or Tyro3 protein activity, for example by competitive or non-competitive ninhibition of the binding interaction between AXL, MER or Tyro3 and its ligand GAS6. |